# Randomized Therapy In Status Epilepticus

> **NCT04391569** · PHASE3 · COMPLETED · sponsor: **Marinus Pharmaceuticals** · enrollment: 100 (actual)

## Conditions studied

- Status Epilepticus

## Interventions

- **DRUG:** Ganaxolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04391569
- **Lead sponsor:** Marinus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-09
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-04-28
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04391569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04391569, "Randomized Therapy In Status Epilepticus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04391569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*